Target intelligence / Profile preview

Gamma-glutamyl cycle

Molecular classification
Other
01

Overview

The gamma-glutamyl cycle is not a single molecule or receptor but rather a biochemical pathway composed of several enzymes that collectively maintain glutathione homeostasis and facilitate amino acid transport. The key enzymes involved include gamma-glutamyl transferase (GGT), gamma-glutamyl cyclotransferase (GGCT), gamma-glutamylcysteine synthetase, glutathione synthetase, 5-oxoprolinase, and others[1][2][3][5]. This pathway is essential for synthesizing and degrading glutathione—a critical antioxidant—and plays roles in detoxification processes as well as cellular protection against oxidative stress[1][3][9]. Inherited defects in any of these component enzymes can result in various metabolic diseases characterized by impaired glutathione metabolism[1]. Note: The "gamma-glutamyl cycle" itself is not considered a therapeutic target; rather, its individual enzyme components may be targets. Therefore, - is_target: false — it is not itself an actionable molecular target like an enzyme or receptor. - is_incorrect: true — this entry refers to an entire pathway/cycle rather than a specific molecular target. For structured data purposes you should instead refer to one of its constituent enzymes such as "Gamma-glutamyl transferase" or "Gamma-glutamyl cyclotransferase"[3][2].

Other names
γ-glutamyl cyclegamma-GT cycleglutathione cycle
02

Biological functions

Glutathione metabolismAmino acid transportDetoxificationOxidative stress regulation
03

Disease associations

Metabolic disorders (e.g., inherited enzyme deficiencies)Neuromuscular disordersHemolytic anemiaLiver disease (indirectly via component enzymes)
04

Safety considerations

Genetic defects in the enzymes of the gamma-glutamyl cycle can lead to metabolic acidosis, hemolytic anemia, neuromuscular symptoms, and other health issues[1].
05

Biomarkers

Gamma-glutamyl transferase activity (as a marker for liver function and oxidative stress)

Beyond the preview

Go deeper on Gamma-glutamyl cycle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-glutamyl cycle.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call